Sign in
4

Changes in Ownership

Altimmune, Inc. Filed Acc 0001012975-17-000635

President and CEO acquired 163,377 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Enright William · President and CEO

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2017-08-16 Exercise or conversion : show line 1 in the form +71,644 $0.08 $5,732 89,431 D
2017-08-16 Exercise or conversion : show line 2 in the form +91,733 $0.08 $7,339 181,164 D

Table II: Derivative

2 lines
Date Transaction Shares Owned after D/I
2017-08-16 Exercise or conversion : show line 3 in the form Stock Options (option to buy) −71,644 0 D
2017-08-16 Exercise or conversion : show line 4 in the form Stock Options (option to buy) −91,733 0 D
Loading xslF345X03/edgar.xml…